Id-1 gene and gene products as therapeutic targets for treatment of breast cancer and other types of carcinoma
Patent
·
OSTI ID:1150642
A method for treatment of breast cancer and other types of cancer. The method comprises targeting and modulating Id-1 gene expression, if any, for the Id-1 gene, or gene products in breast or other epithelial cancers in a patient by delivering products that modulate Id-1 gene expression. When expressed, Id-1 gene is a prognostic indicator that cancer cells are invasive and metastatic.
- Research Organization:
- Lawrence Berkeley National Laboratory (LBNL), Berkeley, CA (United States)
- Sponsoring Organization:
- USDOE
- DOE Contract Number:
- AC03-765F00098
- Assignee:
- California Pacific Medical Center Research Institute (San Francisco, CA); The Regents of the University of California (Oakland, CA)
- Patent Number(s):
- 8,809291
- Application Number:
- 13/252,148
- OSTI ID:
- 1150642
- Country of Publication:
- United States
- Language:
- English
Antisense modulation of inhibitor of DNA binding-1 expression
|
patent | April 2002 |
The helix-loop-helix transcription factor, Id-1, is overexpressed in medullary thyroid cancer
|
journal | December 2000 |
Id-1 and Id-2 Are Overexpressed in Pancreatic Cancer and in Dysplastic Lesions in Chronic Pancreatitis
|
journal | September 1999 |
A Novel Pathway for Mammary Epithelial Cell Invasion Induced by the Helix-Loop-Helix Protein Id-1
|
journal | August 1998 |
Similar Records
Id-1 and Id-2 genes and products as therapeutic targets for treatment of breast cancer and other types of carcinoma
Id-1 and Id-2 genes and products as markers of epithelial cancer
Id-1 and Id-2 genes and products as markers of epithelial cancer
Patent
·
Tue Sep 30 00:00:00 EDT 2014
·
OSTI ID:1150642
Id-1 and Id-2 genes and products as markers of epithelial cancer
Patent
·
Tue Oct 04 00:00:00 EDT 2011
·
OSTI ID:1150642
Id-1 and Id-2 genes and products as markers of epithelial cancer
Patent
·
Tue Sep 30 00:00:00 EDT 2008
·
OSTI ID:1150642